The new formula registration with CFDA will become effective at 1st Jan 2018,there have still 20 months to acheieve it.The new formula registration with CFDA is three parts.
First: all the formula's OEM company (like synlait milk ,Taturra,Murray Goulbour)must be certificated by China government.Here are the company list have already got permit from Australia and Newzealand.
Here are the 8 companies from Australia.
Here are 13companies from Newzealand
That means if the formula brand from Australia and Newzealand want to sale in China,The formula must be manufactured by these company.
Second:
Each enterprise formula company must not exceed 3 series 9 product formulas.Thats policy dont have any influnce for A2 and Bellamy,because they only have one brand ,A2 Platinum and Bellamy Organic and only 3stages for their products.
The most effected by this policy is Danone Nutricia.Danone Nutricia have so many brands in Europe,China,Newzealand like Aptamil and Nutrilon.This why
Danone ends sale of Karicare infant formula in China
Third:
Formula registration.Thats means formula's OEM company (like synlait milk ,Taturra,Murray Goulbour) cant manufacture exceed 5 brands formula. OEM company will remove some brands which not sell very well and hold capacity to satisfied top 5 brands.There also dont have any influnce for A2milk,Because A2 now is the top 1 customer for Synlait milk.
- Forums
- ASX - By Stock
- A2M
- Explain China new tax policy and formula registration with CFDA
Explain China new tax policy and formula registration with CFDA, page-4
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31146 | 7.400 |
1 | 607 | 7.270 |
1 | 5 | 7.250 |
7 | 20893 | 7.200 |
17 | 124660 | 7.190 |
Price($) | Vol. | No. |
---|---|---|
6.320 | 293 | 1 |
6.380 | 28866 | 5 |
6.420 | 922 | 1 |
6.450 | 310 | 1 |
6.500 | 22398 | 7 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online